DANAHER CORP 20/26DANAHER CORP 20/26DANAHER CORP 20/26

DANAHER CORP 20/26

No trades
See on Supercharts

XS214799529 analysis



Key facts


Issue date
Mar 30, 2020
Maturity date
Sep 30, 2026
Outstanding amount
‪800.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
2.10% (Fixed)
Yield to maturity
2.35%
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.